Get the Stockscreener App
338.81
0.83%
-2.83
After Hours:
338.81
Beone Medicines Ltd Adr stock is traded at $338.81, with a volume of 242.76K.
It is down -0.83% in the last 24 hours and up +8.12% over the past month.
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
See More
Previous Close:
$341.64
Open:
$331.18
24h Volume:
242.76K
Relative Volume:
0.86
Market Cap:
$37.49B
Revenue:
$4.98B
Net Income/Loss:
$69.59M
P/E Ratio:
651.93
EPS:
0.5197
Net Cash Flow:
$525.67M
1W Performance:
+0.15%
1M Performance:
+8.12%
6M Performance:
+14.62%
1Y Performance:
+52.47%
1-Day Range:
$331.18
$342.00
1-Week Range:
$325.10
$344.81
52-Week Range:
$196.45
$385.22
Beone Medicines Ltd Adr Stock (ONC) Company Profile
Name
Beone Medicines Ltd Adr
Sector
Industry
Phone
41-616851900
Address
C/O BEONE MEDICINES I GMBH, BASEL
Compare ONC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONC
Beone Medicines Ltd Adr
|
338.81 | 37.81B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.35 | 117.00B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.51 | 78.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
827.02 | 50.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
370.00 | 48.28B | 3.21B | 43.57M | 221.36M | 0.2405 |
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-25 | Initiated | Truist | Buy |
| Sep-18-25 | Initiated | Barclays | Overweight |
| Apr-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Mar-03-25 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-03-24 | Resumed | Morgan Stanley | Overweight |
| Sep-18-24 | Initiated | JMP Securities | Mkt Outperform |
| Feb-06-24 | Resumed | JP Morgan | Overweight |
| Sep-12-23 | Initiated | Macquarie | Outperform |
| Aug-17-23 | Initiated | Jefferies | Buy |
| Jul-17-23 | Initiated | Citigroup | Buy |
| Jun-30-23 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jan-12-23 | Initiated | Daiwa Securities | Buy |
| Oct-13-22 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-13-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Aug-09-22 | Resumed | JP Morgan | Overweight |
| Mar-17-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Feb-07-22 | Initiated | Deutsche Bank | Buy |
| Oct-12-21 | Initiated | Bernstein | Outperform |
| Oct-06-21 | Upgrade | CLSA | Underperform → Buy |
| Mar-08-21 | Initiated | China Renaissance | Buy |
| Mar-01-21 | Downgrade | CLSA | Outperform → Underperform |
| Nov-09-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Nov-06-20 | Downgrade | Maxim Group | Buy → Hold |
| Nov-06-20 | Downgrade | Piper Sandler | Neutral → Underweight |
View All
Beone Medicines Ltd Adr Stock (ONC) Latest News
BeOne Medicines (NASDAQ:ONC) Shares Gap DownShould You Sell? - MarketBeat
BEONE MEDICINES LTD-ADR (NASDAQ:ONC) Passes Minervini Trend Template and Strong Growth Scan - Chartmill
Five Below Upgraded, Spotify Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Short Interest Up 24.1% in December - MarketBeat
CICC Predicts HSI to Add ZIJIN GOLD INTL/ BEONE MEDICINES/ PICC P&C/ AKESO as New Constituents; STANCHART May Replace HANG SENG BANK - AASTOCKS.com
Assessing BeOne Medicines (ONC) Valuation After A Year Of Strong Shareholder Returns - Sahm
HERIZON-GEA-01 Phase 3 Zanidatamab Combo Data Might Change The Case For Investing In BeOne Medicines (ONC) - Sahm
Chan Henry Lee Sells 664 Shares of BeOne Medicines (NASDAQ:ONC) Stock - Defense World
JGP Global Gestao de Recursos Ltda. Decreases Stock Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Clear Harbor Asset Management LLC Takes Position in Canadian Natural Resources Limited $CNQ - Defense World
Schwab US Dividend Equity ETF $SCHD Shares Sold by Fjell Capital LLC - Defense World
BeOne Medicines (NASDAQ:ONC) SVP Chan Henry Lee Sells 664 Shares - MarketBeat
Is the Options Market Predicting a Spike in BeOne Medicines Stock? - Yahoo Finance
Jazz Pharmaceuticals' Drug Extends Survival Past Two Years in Advanced Stomach Cancer Trial - Sahm
Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit - GlobeNewswire Inc.
BrightSpire Capital (NYSE:BRSP) Shares Gap Down – Here’s What Happened - Defense World
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Voya Investment Management LLC Raises Holdings in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
John Oyler Sells 75,631 Shares of BeOne Medicines (NASDAQ:ONC) Stock - Defense World
BeOne Medicines appoints Dr. Lai Wang as president and global head of R&D - Investing.com
BeOne Medicines (NASDAQ:ONC) CEO John Oyler Sells 24,369 Shares - MarketBeat
BeOne Medicines (NASDAQ:ONC) Shares Gap Down After Insider Selling - Defense World
BeOne Medicines (NASDAQ:ONC) Shares Gap Down Following Insider Selling - MarketBeat
Ford Upgraded, Amazon Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
LMR Partners LLP Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
China Universal Asset Management Co. Ltd. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) SVP Sells $107,900.00 in Stock - MarketBeat
35,910 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Purchased by Axa S.A. - Defense World
Bellevue Group AG Makes New $9.37 Million Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
35,910 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Axa S.A. - MarketBeat
Lee Chan Henry, SVP at BeOne Medicines, sells shares worth $213,568 - Investing.com
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases Shares of 9,377 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
12,338 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Purchased by American Century Companies Inc. - Defense World
8,037 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Acquired by Guggenheim Capital LLC - MarketBeat
First Trust Advisors LP Makes New Investment in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
First Trust Advisors LP Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
12,338 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by American Century Companies Inc. - MarketBeat
Temasek Holdings Private Ltd Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Nan Fung Group Holdings Ltd Makes New $3.81 Million Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Jump Financial LLC Invests $17.02 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Russell Investments Group Ltd. Acquires Shares of 13,603 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
7,707 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Tema Etfs LLC - MarketBeat
Walleye Capital LLC Purchases Shares of 36,645 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
467,590 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Marshall Wace LLP - MarketBeat
3,330 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Qtron Investments LLC - MarketBeat
Baird Financial Group Inc. Invests $82.90 Million in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Hsbc Holdings PLC Invests $4.99 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Geode Capital Management LLC Acquires New Holdings in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Baird Financial Group Inc. Invests $82.90 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Mackenzie Financial Corp Purchases Shares of 41,328 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Beone Medicines Ltd Adr Stock (ONC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):